WS #13344
Holding: newest synthesis is 99d 20h old
AstraZeneca falls ~8% on reports of exploring $400B merger with Bristol Myers Squibb, dragging UK pharma and FTSE.
AstraZeneca-Bristol Myers merger talks
AstraZeneca falls ~8% on reports of exploring $400B merger with Bristol Myers Squibb, dragging UK pharma and FTSE.